Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 2:20 PM UTC
| NCT Number | NCT06980480 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE3 |
| Target Enrollment | 183 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | October 13, 2026 (14 hours ago) |
As of October 13, 2026: Clinical trial NCT06980480 is currently recruiting participants. This phase3 study for multiple myeloma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06980480 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06980480 was last updated 14 hours ago (October 13, 2026). HelloStudys verifies this status automatically.